2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine | CAS:1616841-66-7

We serve 2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine CAS:1616841-66-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine

Chemical Name:2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
CAS.NO:1616841-66-7
Synonyms:1,3,5-Triazine, 2-(4-bromophenyl)-4,6-di-2-naphthalenyl-
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
2-(4-bromophenyl)-4,6-di-2-naphthalenyl-1,3,5-Triazine
Molecular Formula:C29H18BrN3
Molecular Weight:488.37700
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine1,3,5-Triazine, 2-(4-bromophenyl)-4,6-di-2-naphthalenyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-bromophenyl)-4,6-di-2-naphthalenyl-1,3,5-Triazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine1,3,5-Triazine, 2-(4-bromophenyl)-4,6-di-2-naphthalenyl- Use and application,2-(4-bromophenyl)-4,6-di-2-naphthalenyl-1,3,5-Triazine technical grade,usp/ep/jp grade.


Related News: The primary endpoint of INSPIRE is overall survival. The trial continued beyond the pre-specified interim analysis and is nearing its conclusion.3-bromo-1,2-difluoro-4-nitrobenzene manufacturer Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday.3-Pyridylacetic Acid Hydrochloride supplier Under the plan, nonessential hospital staff members who belong to the union would not go to work on Monday.3-[1-(Dimethylamino)ethyl]phenol vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country.